These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20551301)

  • 1. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L; Hermes-Desantis ER
    Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes.
    Avitabile N; Banka A; Fonseca VA
    Expert Opin Drug Saf; 2011 Mar; 10(2):305-10. PubMed ID: 21244342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
    Brunetti L; Campbell RK
    J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
    Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH; Donovan JM; Misir S; Jones MR
    Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
    Levy P
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colesevelam hydrochloride: a novel bile acid-binding resin.
    Aldridge MA; Ito MK
    Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
    Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
    Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What role for [black triangle down] colesevelam in cardiovascular prevention?
    Drug Ther Bull; 2009 May; 47(5):53-5. PubMed ID: 19423677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H; Rhyne J; Abby S; Lai YL; Jones M
    Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.
    Goldfine AB; Fonseca VA; Jones MR; Wang AC; Ford DM; Truitt KE
    Horm Metab Res; 2010 Jan; 42(1):23-30. PubMed ID: 19862667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
    Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR
    Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS; Fong NT
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE
    Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus.
    Sonnett TE; Levien TL; Neumiller JJ; Gates BJ; Setter SM
    Clin Ther; 2009 Feb; 31(2):245-59. PubMed ID: 19302898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colesevelam: a review of its use in hypercholesterolemia.
    Robinson DM; Keating GM
    Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.